Full Text View
Tabular View
No Study Results Posted
Related Studies
Effect of Palivizumab on Later Recurrent Wheezing in Preterm Infants
This study has been completed.
Study NCT01072552   Information provided by Tokyo Women's Medical University

First Received on December 21, 2009.   Last Updated on April 1, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Recurrent Wheezing
Wheezing
Asthma
Additional conditions recognized in this trial
Respiratory Sounds
More general conditions related to this trial
Bronchial Diseases
Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases
Lung Diseases
Lung Diseases, Obstructive
Respiratory Hypersensitivity
Respiratory Tract Diseases
Signs and Symptoms
Signs and Symptoms, Respiratory
Additional drug interventions recognized in this trial
Palivizumab
More general drug interventions related to this trial
Anti-Infective Agents
Antiviral Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Satoshi Kusuda
Scientific Committee of Recurrent Wheezing


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services